Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-05-02 @ 1:43 AM
Study NCT ID:
NCT05400603
Status:
RECRUITING
Last Update Posted:
2025-09-15
First Post:
2022-05-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
Sponsor:
Organization: